-
www.ahrq.gov/news/newsletters/e-newsletter/925.html
August 01, 2024 - New Data Files Provide Comprehensive View of U.S. Healthcare
Issue Number
925
AHRQ News Now is a weekly newsletter that highlights agency research and program activities.
August 13, 2024
AHRQ Stats: Sepsis-Related Mortality Before and During COVID-19 Between 2016 and 2019, the in-hospital mortality rate…
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-6mon-post-intervention-sw.pdf
April 03, 2017 - practice uses clinical guidelines for management of
patients at risk for cardiovascular disease (e.g., statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-ok.pdf
November 01, 2017 - EvidenceNow Executive Summary - Oklahoma Cooperative
Oklahoma Cooperative
Oklahoma
EvidenceNOW: Advancing Heart Health in Primary Care is an initiative of the Agency for Healthcare
Research and Quality (AHRQ) to transform health care delivery by building a critical infrastructure
to help smaller primary ca…
-
cdsic.ahrq.gov/sites/default/files/2023-10/Final%20OO%20Patient%20Outcomes%20of%20PC%20CDS%20to%20AHRQ%2010.6.23.pdf
January 01, 2023 - adherence measures were identified in CDS
studies, including patient-reported measures such as the Statin … measures identified have general usability for various types
of medication interventions; however, the Statin … ratio of the days of
medication supplied for a period over the duration
of the period.37
No N/A
Statin … determine whether
patients were taking statins and, using a single
question, whether they had missed any statin … Helping Patients With Type 2 Diabetes Mellitus Make Treatment Decisions:
Statin Choice Randomized Trial
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - difficult to distinguish harms from
failed treatments (e.g., myocardial infarction in patients on statin … toxicity
Biopsy: bleeding; nosocomial
infection
Combination Therapy
Versus Intensification of
Statin … Dual agent therapy (statin
+ lipid modifying
medication) and
intensification of statin
therapy
-
www.ahrq.gov/sites/default/files/2024-01/wessell2-report.pdf
January 01, 2024 - Final Progress Report: Reducing Adverse Drug Events From Anticoagulants, Diabetes Agents and Opioids in Primary Care
Final Progress Report
Reducing Adverse Drug Events from Anticoagulants, Diabetes Agents and Opioids in
Primary Care
Principal Investigator: Andrea M. Wessell, PharmD
Team Members: Steven M. Orns…
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-6mon-post-intervention.pdf
June 02, 2025 - practice uses clinical guidelines for management of patients at risk for cardiovascular disease (e.g.,
statin
-
digital.ahrq.gov/sites/default/files/docs/cds-authoring-tool-qas-020719.pdf
December 08, 2017 - For an example, see the alternate statin use configuration. … https://cds-hooks.org/
https://github.com/AHRQ-CDS/AHRQ-CDS-Connect-CQL-SERVICES/blob/master/localHooks/statin-use.json.alternate
-
effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
August 01, 2009 - AHRQ Slide Template 2009
Presentation of Findings
Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Methods Guide for Effectiveness and Comparative Effectiveness Reviews
Presentation of Findings
Systematic Review Process Overview
Systematic Review Process Overview
This slide illustrates th…
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/ehr-reports.pdf
March 01, 2016 - An example
would be patients with a 5-year risk of a
cardiovascular event > 7.5% who have a statin … their cholesterol tested in the past two years and,
of those whose LDL was > 70, the percent on a statin
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan151/lipid-disorders-in-children-screening-july-2016
January 15, 2015 - Does initiation of statin treatment of familial hypercholesterolemia in childhood or adolescence result
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.182_slideshow.ppt
September 01, 2008 - post-menopausal, has an unremarkable past medical history and no allergies, and her only medications are a statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-baseline.pdf
June 02, 2025 - Practice Survey Codebook: CPCQ and PCMH-A
EvidenceNow Practice Survey Codebook: CPCQ and PCMH-A
.
Variable Name/ Core-
optional Status Item
We would like to learn about the strategies that your practice uses to improve cardiovascular preventive care (e.g., prescribing aspirin for patients at
risk for ische…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
January 01, 2017 - more than half of the alerts that would
have been triggered for DDIs involving cholesterol-lowering statin … drugs were inappropriate because the dose
of the statin was not considered by the software.24 More … Successful strategy to improve the specificity of electronic
statin-drug interaction alerts.
-
www.ahrq.gov/sites/default/files/2024-07/morrison-report.pdf
January 01, 2024 - Jones for hyperlipidemia and is on a statin drug.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - As noted
in the statin example above, the exposure time
window to evaluate the effectiveness of statins
-
www.ahrq.gov/sites/default/files/2024-07/zhou-report.pdf
January 01, 2024 - Final Progress Report: Encoding and Processing Patient Allergy Information in EHRs
AHRQ Grant Final Progress Report
Title of Project:
Encoding and Processing Patient Allergy Information in EHRs
Principal Investigator:
Li Zhou, MD, PhD
Associate Professor
Brigham and Women’s Hospital, Harvard Medical School
Team…
-
www.ahrq.gov/sites/default/files/2024-01/wessell-report.pdf
January 01, 2024 - Drug-Drug Interactions
• Macrolide antibiotics and digoxin
• Tetracycline and digoxin
• Itraconazole and statin
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs019726-kahn-final-report-2014.pdf
January 01, 2014 - 39400065 sertraline 58160070
Simvastatin 39400075
SNRI 5818 duloxetine 58180025
Combination,Products,(statin
-
www.ahrq.gov/sites/default/files/2024-02/ornstein-report.pdf
January 01, 2024 - • Avoidance of itraconazole and statin.
5
• Avoidance of lithium and thiazide.